Citius Oncology
CTOR
15 hedge funds and large institutions have $46.9M invested in Citius Oncology in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 12 closing their positions.
32% less capital invested
Capital invested by funds: $69M → $46.9M (-$22.1M)
35% less funds holding
Funds holding: 23 → 15 (-8)
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$4.88M |
| 2 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$4.11M |
| 3 |
QL
Quarry LP
New York
|
+$2.2M |
| 4 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
+$1.81M |
| 5 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$1.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$5.52M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$3.93M |
| 3 |
KL
KIM LLC
Wichita,
Kansas
|
-$3.56M |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$2.48M |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$2.26M |
CTOR Hedge Fund Activity: Q1 2024 in Review
15 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Citius Oncology (CTOR) for Q1 2024, worth a combined $46.9M — down 32% from $69M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CTOR and 4 opened new positions — a net loss of 8 holders — while 6 trimmed existing stakes and 2 added.
The largest buyer was Cowen and Company, adding an estimated $4.88M. The largest seller was Karpus Investment Management, exiting entirely with an estimated $5.52M sold.
- 15 institutional investors held Citius Oncology (CTOR) as of Q1 2024, down from 23 in Q4 2023.
- Funds reported $46.9M of Citius Oncology stock for Q1 2024, down 32% quarter-over-quarter.
- 4 funds opened new Citius Oncology positions in Q1 2024 and 12 closed out, a net change of -8 holders.
- The largest Citius Oncology buyer in Q1 2024 was Cowen and Company, an estimated $4.88M added.
- The largest Citius Oncology seller in Q1 2024 was Karpus Investment Management, an estimated $5.52M sold.
Based on aggregated 13F filings for Q1 2024.